Navigation Links
Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved

Reports of the death of four Californian women due to the toxic shock syndrome following consumption of the abortion pill RU-486 (Mifeprex) has created much confusion // and controversy among members of the scientific community.

It has been confirmed by health officials that it is due to the toxins produced by the highly lethal bacteria - Clostridium sordellii. So far, there have been only 10 reports of the fatal infection, 8 of which were in women who had given birth to live infants. One other was associated with an abortion, and the remaining one was not associated with pregnancy at all. It is still unclear if something in the abortion pill that could have caused the tragedy by increasing the chances of the infection.

Identifying C. sordellii infection in women who have induced abortion is complicated owing to the fact that there is similarity between the symptoms in by the fact that early symptoms (abdominal cramping, nausea, vomiting) tend to be the same as those experienced normally.

The abortion pill was first approved for termination of early pregnancy (7 week duration or less) in the United States in the year 2000. Since then, more than 460,000 doses of the medication have been distributed.

If the four deaths were the only ones to have occurred after using the drug, probably it would indicate that women who use it for induced abortion face a higher risk of contracting the infection. This would be approximate to a 10 times higher than the risk associated with surgical abortions performed early in pregnancy.

The biggest mystery relating to the tragedy is the incidence of all four cases in a single state while the FDA confirms the uniform frequency of drug usage throughout California. The CDC is hoping to raise awareness about the potential risks with the new report.

In view of the above report, may be it is time for doctors to closely examine the potential risks of any medication prescribed and keep a watch over any specific symptoms that could be a sign of the impending mortality.


'"/>




Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Understanding The Mystery Behind Sleepless Nights
3. Mystery of nacrolepsy uncovered
4. Cholesterol Mystery Solved By Nobel Laureates
5. A Step Towards Unraveling The Schizophrenia And Depression Mystery
6. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
7. Mystery behind Brain activity during recalling events disentangled
8. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
9. Mystery Of The Placebo Effect, Yet To Be Solved
10. Dry Earwax Mystery Solved: Ear Wax Gene Identified
11. Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolvd
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: